| 1 | 19 NOR vitamin D | - | - | - | - | 1件: 13 13 💬
|
| 2 | 2% chlorhexidine solution wipes (Nolvasan) | 1件: Chlorhexidine Chlorhexidine | 4件: Chlorhexidine gluconate
Chlorhexidine gluconate
,
Chlorhexidine hydrochloride
,
Chlorhexidine
,
Chlorhexidine acetate
(Nolvasan) 💬
| - | - | 1件: 299 299 💬
|
| 3 | 4% chlorhexidine gluconate liquid skin cleanser (Nolvasan) | - | - | - | - | 1件: 299 299 💬
|
| 4 | A novel synthetic, orally-administered, NON-peptide small molecule, which acts AS | - | - | - | - | 1件: 254 254 💬
|
| 5 | Administration OF AN ACE-inhibitor or NOT | - | - | - | - | 1件: 210 210 💬
|
| 6 | Alcohol wipes VS. NO alcohol wipes | 1件: Ethanol Ethanol | 3件: Alcohol
Alcohol
,
Isopropanol and methylated alcohol
,
Ethanol
💬
| - | - | 1件: 13 13 💬
|
| 7 | Amikin, amiklin, amicacin, BB-K8, biklin, fabianol, kaminax, mikavir, novamin, pierami | 1件: Amikacin Amikacin | 2件: Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | 1件: 299 299 💬
|
| 8 | Amikin®, amiklin, amicacin, BB-K8, biklin®, fabianol®, kaminax, mikavir, novamin®, pierami | 1件: Amikacin Amikacin | 2件: Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | 1件: 299 299 💬
|
| 9 | Amlodipine (Norvasc, NORLIQVA, NORVASC) | 1件: Amlodipine Amlodipine | 4件: Amlodipine besylate
Amlodipine besylate
(Norvasc, NORLIQVA, NORVASC),
Amlodipine maleate
,
Amlodipine
(Norvasc),
Amlodipine benzoate
💬
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 67 67, 298 💬
|
| 10 | Amlodipine GEL (Norvasc, NORLIQVA, NORVASC) | 1件: Amlodipine Amlodipine | 4件: Amlodipine besylate
Amlodipine besylate
(Norvasc, NORLIQVA, NORVASC),
Amlodipine maleate
,
Amlodipine
(Norvasc),
Amlodipine benzoate
💬
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬
|
| 11 | Amoxicillin, metronidazole and doxycycline (Noritate, NORITATE) | 1件: Amoxicillin Amoxicillin | 3件: Amoxicillin
Amoxicillin
,
Amoxicillin sodium
,
Amoxicillin
💬
| - | - | 1件: 97 97 💬
|
| 12 | ANI (analgesia/nociception index) monitoring | - | - | - | - | 1件: 22 22 💬
|
| 13 | Assessment OF motor and NON-motors symptoms OF PD evaluation OF hyper- and hypodopaminergic behaviors | - | - | - | - | 1件: 6 6 💬
|
| 14 | Atazanavir/ritonavir (Norvir, NORVIR) | 1件: Atazanavir Atazanavir | 2件: Atazanavir sulfate
Atazanavir sulfate
,
Atazanavir
💬
| - | - | 1件: 265 265 💬
|
| 15 | Azithromycin + metronidazole (Noritate, NORITATE) | 2件: Azithromycin Azithromycin, Metronidazole | 5件: Metronidazole
Metronidazole
(Noritate, NORITATE),
Azithromycin hydrate
,
Metronidazole hydrochloride
,
Azithromycin
,
Azithromycin
💬
| - | - | 1件: 96 96 💬
|
| 16 | AúN NO establecido | - | - | - | - | 1件: 53 53 💬
|
| 17 | Best medical treatment (BMT): adjustment OF THE dopaminergic medication and NON-dopaminergic therapy customized FOR each patient according TO THE latest published consensus group recommendations | - | - | - | - | 1件: 6 6 💬
|
| 18 | BIA 9-1067 NON-micronized | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 19 | Bladder tissue OF interstitial cystitis and normal bladder tissue | - | - | - | - | 1件: 226 226 💬
|
| 20 | Botox 100U IN normal saline | - | - | - | - | 1件: 226 226 💬
|
| 21 | Botox 200U IN normal saline | - | - | - | - | 1件: 226 226 💬
|
| 22 | Candesartan plus NON-CCB agents | 1件: Candesartan Candesartan | 1件: Candesartan
Candesartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 67 67 💬
|
| 23 | CAS NO.: 7758-16-9 | - | - | - | - | 1件: 166 166 💬
|
| 24 | Catridecacog (NovoThirteen) | 1件: Catridecacog Catridecacog | 1件: Catridecacog
Catridecacog
(NovoThirteen) 💬
| - | - | 2件: 97 97, 288 💬
|
| 25 | CBD - solution orale, conosciuto come epidiolex, questo è IL nome approvato negli stati uniti | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 💬
|
| 26 | CBD soluzione orale nota come epidyolex E CON tale nome è stato approvato IN UE | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 💬
|
| 27 | Celulas madre mesenquimales troncales adultas alogenicas DE Médula óSEA NO expandida | - | - | - | - | 1件: 274 274 💬
|
| 28 | Chlorhexidine (Nolvasan) | 1件: Chlorhexidine Chlorhexidine | 4件: Chlorhexidine gluconate
Chlorhexidine gluconate
,
Chlorhexidine hydrochloride
,
Chlorhexidine
,
Chlorhexidine acetate
(Nolvasan) 💬
| - | - | 1件: 86 86 💬
|
| 29 | Chlorhexidine gluconate (Nolvasan) | 1件: Chlorhexidine Chlorhexidine | 4件: Chlorhexidine gluconate
Chlorhexidine gluconate
,
Chlorhexidine hydrochloride
,
Chlorhexidine
,
Chlorhexidine acetate
(Nolvasan) 💬
| - | - | 1件: 299 299 💬
|
| 30 | Chlorhexidine gluconate oral rinse (Nolvasan) | 1件: Chlorhexidine Chlorhexidine | 4件: Chlorhexidine gluconate
Chlorhexidine gluconate
,
Chlorhexidine hydrochloride
,
Chlorhexidine
,
Chlorhexidine acetate
(Nolvasan) 💬
| - | - | 1件: 299 299 💬
|
| 31 | Coenzyme Q-10 IN normal control subjects | 1件: Ubidecarenone Ubidecarenone | 1件: Ubidecarenone
Ubidecarenone
💬
| - | - | 1件: 86 86 💬
|
| 32 | Cpap group: postoperative cpap support, NON-cpap group: oxygen 3 liters PER minute (L/MIN) either VIA mask FOR those WHO were extubated or through A T-piece FOR those with A trash | - | - | - | - | 1件: 330 330 💬
|
| 33 | CRN00808 IS AN oral NON-peptide small molecule somatostatin receptor 2 (SST2) agonist | 1件: Somatostatin Somatostatin | 1件: Somatostatin
Somatostatin
💬
| 5件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
| 34 | CRN00808 è UN agonista DEL recettore 2 della somatostatina (SST2), orale, NON peptidico A piccole dimensioni molecolari | - | - | - | - | 1件: 77 77 💬
|
| 35 | Células mesenquimales troncales adultas alogénicas DE Médula óSEA NO expandidas | - | - | - | - | 1件: 274 274 💬
|
| 36 | DE-implementation OF inhaled nitric oxide (INO) USE (NOXIVENT 101, NOXIVENT 102) | 1件: Nitric Oxide Nitric Oxide | 1件: Nitric oxide
Nitric oxide
(NOXIVENT 101, NOXIVENT 102) 💬
| - | - | 1件: 294 294 💬
|
| 37 | Desipramine (Norpramin) | 1件: Desipramine Desipramine (Norimipramine) | 2件: Desipramine hydrochloride
Desipramine hydrochloride
(Norpramin),
Desipramine
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 121 121 💬
|
| 38 | Dietary intervention with NO-carrageenan diet | - | - | - | - | 1件: 97 97 💬
|
| 39 | Droxidopa (Northera, NORTHERA) | 1件: Droxidopa Droxidopa | 1件: Droxidopa
Droxidopa
(Northera, NORTHERA) 💬
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 5 5, 6, 17, 169, 170 💬
|
| 40 | Exhaled nitric oxide (NOXIVENT 101, NOXIVENT 102) | - | - | - | - | 1件: 299 299 💬
|
| 41 | Extavia (interferon BETA-1B), novartis pharma AG | 2件: Human interferon beta Human interferon beta, Interferon beta-1b | 2件: Interferon beta-1b
Interferon beta-1b
,
Interferon beta
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 42 | GA-68-DOTA-NOC | - | - | - | - | 1件: 84 84 💬
|
| 43 | Gallium68-DOTA-NOC | - | - | - | - | 1件: 85 85 💬
|
| 44 | Gamma-secretase/notch signalling pathway inhibitor RO4929097 | - | - | - | - | 1件: 74 74 💬
|
| 45 | Glatiramer acetate 20 MG, with mitoxantrone (Novantron) | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 46 | GM-CSF, fosfomycin and metronidazole (Noritate, NORITATE) | - | - | - | - | 1件: 97 97 💬
|
| 47 | GSK2018682 CD3 NON-micronised tablet IN FED state | - | - | - | - | 1件: 13 13 💬
|
| 48 | Hemin (Normosang) | 1件: Hemin Hemin | 1件: Hemin
Hemin
(Normosang) 💬
| 2件: E2.3.1.37 E2.3.1.37, E2.3.1.37 💬
| 2件: Glycine, serine and threonine metabolism Glycine, serine and threonine metabolism, Porphyrin metabolism 💬 | 1件: 254 254 💬
|
| 49 | Hemin FOR injection (Normosang) | 1件: Hemin Hemin | 1件: Hemin
Hemin
(Normosang) 💬
| 2件: E2.3.1.37 E2.3.1.37, E2.3.1.37 💬
| 2件: Glycine, serine and threonine metabolism Glycine, serine and threonine metabolism, Porphyrin metabolism 💬 | 1件: 254 254 💬
|
| 50 | Human immunoglobulin G (Human normal immunoglobulin) | 1件: Human immunoglobulin G Human immunoglobulin G (Human normal immunoglobulin) | 1件: Globulin, immune
Globulin, immune
(Human normal immunoglobulin) 💬
| - | - | 3件: 14 14, 50, 63 💬
|
| 51 | Human normal immunoglobulin | 1件: Human immunoglobulin G Human immunoglobulin G (Human normal immunoglobulin) | 1件: Globulin, immune
Globulin, immune
(Human normal immunoglobulin) 💬
| - | - | 8件: 11 11, 13, 14, 43, 45, 50, 63, 65 💬
|
| 52 | Human normal immunoglobulin FOR intravenous (IV) administration | 1件: Human immunoglobulin G Human immunoglobulin G (Human normal immunoglobulin) | 1件: Globulin, immune
Globulin, immune
(Human normal immunoglobulin) 💬
| - | - | 1件: 51 51 💬
|
| 53 | Human normal immunoglobulin FOR intravenous administration | 1件: Human immunoglobulin G Human immunoglobulin G (Human normal immunoglobulin) | 1件: Globulin, immune
Globulin, immune
(Human normal immunoglobulin) 💬
| - | - | 3件: 14 14, 51, 65 💬
|
| 54 | Human normal immunoglobulin FOR intravenous USE | 1件: Human immunoglobulin G Human immunoglobulin G (Human normal immunoglobulin) | 1件: Globulin, immune
Globulin, immune
(Human normal immunoglobulin) 💬
| - | - | 2件: 63 63, 65 💬
|
| 55 | Human normal immunoglobulin FOR intrvenous USE | 1件: Human immunoglobulin G Human immunoglobulin G (Human normal immunoglobulin) | 1件: Globulin, immune
Globulin, immune
(Human normal immunoglobulin) 💬
| - | - | 1件: 63 63 💬
|
| 56 | Human normal immunoglobulin FOR subcutaneous administration | 1件: Human immunoglobulin G Human immunoglobulin G (Human normal immunoglobulin) | 1件: Globulin, immune
Globulin, immune
(Human normal immunoglobulin) 💬
| - | - | 2件: 51 51, 65 💬
|
| 57 | Human recombinant tissue NON-specific alkaline phosphatase fusion protein | - | - | - | - | 1件: 172 172 💬
|
| 58 | Immunoglobulin G1, anti (protein nogo A) (human MUS musculus monoclonal heavy | - | - | - | - | 1件: 2 2 💬
|
| 59 | Immunoglobulin G1, anti (protein nogo A) (human MUS musculus monoclonal heavy chain), disulfide with human MUS musculus monoclonal light chain, dimer | - | - | - | - | 1件: 2 2 💬
|
| 60 | Immunoglobulina normale umana PER somministrazione endovenosa | - | - | - | - | 1件: 51 51 💬
|
| 61 | Immunoglobulina normale umana PER somministrazione sottocutanea | - | - | - | - | 1件: 51 51 💬
|
| 62 | Immunoglobulina umana normale | - | - | - | - | 3件: 51 51, 63, 65 💬
|
| 63 | Immunoglobulina umana normale PER somministrazione endovenosa | - | - | - | - | 1件: 14 14 💬
|
| 64 | Immunoglobulins, normal human | - | - | - | - | 1件: 65 65 💬
|
| 65 | Inhaled nitric oxide (NOXIVENT 101, NOXIVENT 102) | - | - | - | - | 2件: 85 85, 86 💬
|
| 66 | Inhaled nitric oxide & inopulse delivery (NOXIVENT 101, NOXIVENT 102) | 1件: Nitric Oxide Nitric Oxide | 1件: Nitric oxide
Nitric oxide
(NOXIVENT 101, NOXIVENT 102) 💬
| - | - | 1件: 86 86 💬
|
| 67 | Inhaled nitric oxide - 30 MCG/KG IBW/HR (NOXIVENT 101, NOXIVENT 102) | - | - | - | - | 1件: 85 85 💬
|
| 68 | Inhaled nitric oxide 5,10,15 MCG/KG IBW/HR (NOXIVENT 101, NOXIVENT 102) | - | - | - | - | 1件: 85 85 💬
|
| 69 | Inhaled nitric oxide 75 MCG/KG IBW/HR (NOXIVENT 101, NOXIVENT 102) | - | - | - | - | 2件: 85 85, 86 💬
|
| 70 | Inhaled NO with pulsed delivery | - | - | - | - | 1件: 86 86 💬
|
| 71 | Injection OF normal saline | - | - | - | - | 1件: 6 6 💬
|
| 72 | INN NOT available | - | - | - | - | 2件: 19 19, 46 💬
|
| 73 | INN NOT available AT this time | - | - | - | - | 1件: 6 6 💬
|
| 74 | INN NOT available YET | - | - | - | - | 1件: 222 222 💬
|
| 75 | INN NOT YET proposed | - | - | - | - | 1件: 193 193 💬
|
| 76 | Istradefylline (Nourianz, Nouriast, NOURIANZ) | 1件: Istradefylline Istradefylline | 1件: Istradefylline
Istradefylline
(Nourianz, Nouriast, NOURIANZ) 💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 77 | Istradefylline 20 MG (Nourianz, Nouriast, NOURIANZ) | 1件: Istradefylline Istradefylline | 1件: Istradefylline
Istradefylline
(Nourianz, Nouriast, NOURIANZ) 💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 78 | Istradefylline 20 MG or 40 MG (Nourianz, Nouriast, NOURIANZ) | 1件: Istradefylline Istradefylline | 1件: Istradefylline
Istradefylline
(Nourianz, Nouriast, NOURIANZ) 💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 79 | Istradefylline 40 MG (Nourianz, Nouriast, NOURIANZ) | 1件: Istradefylline Istradefylline | 1件: Istradefylline
Istradefylline
(Nourianz, Nouriast, NOURIANZ) 💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 80 | Istradefylline medication (Nourianz, Nouriast, NOURIANZ) | 1件: Istradefylline Istradefylline | 1件: Istradefylline
Istradefylline
(Nourianz, Nouriast, NOURIANZ) 💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 81 | Istradefylline pill (Nourianz, Nouriast, NOURIANZ) | 1件: Istradefylline Istradefylline | 1件: Istradefylline
Istradefylline
(Nourianz, Nouriast, NOURIANZ) 💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 82 | IV deployment OF csvf IN sterile normal saline IV solution | - | - | - | - | 2件: 85 85, 229 💬
|
| 83 | Lamotrigin ”nordic prime 100 MG | - | - | - | - | 1件: 114 114 💬
|
| 84 | Lamotrigin ”nordic prime 25 MG | - | - | - | - | 1件: 114 114 💬
|
| 85 | Lamotrigin ”nordic prime 50 MG | - | - | - | - | 1件: 114 114 💬
|
| 86 | Lenadogene nolparvovec | 1件: Lenadogene nolparvovec Lenadogene nolparvovec (Lenadogene nolparvovec) | - | - | - | 1件: 302 302 💬
|
| 87 | Levobupivacaine (Novabupi) | 1件: Levobupivacaine Levobupivacaine | 2件: Levobupivacaine hydrochloride
Levobupivacaine hydrochloride
,
Levobupivacaine
(Novabupi) 💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 46 46 💬
|
| 88 | Levonorgestrel (Norplant) | 1件: Levonorgestrel Levonorgestrel (17alpha-Ethynyl-18-homo-19-nortestosterone) | 1件: Levonorgestrel
Levonorgestrel
(Norplant) 💬
| 1件: PGR PGR 💬
| 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 13 13 💬
|
| 89 | Local injection OF normal saline | - | - | - | - | 1件: 96 96 💬
|
| 90 | Lopinavir/ritonavir (Norvir, NORVIR) | 1件: Lopinavir Lopinavir | 1件: Lopinavir
Lopinavir
💬
| - | - | 1件: 265 265 💬
|
| 91 | Lopinavir/ritonavir + nevirapine (Norvir, NORVIR) | 1件: Lopinavir Lopinavir | 1件: Lopinavir
Lopinavir
💬
| - | - | 1件: 265 265 💬
|
| 92 | Lopinavir/ritonavir + zidovudine + lamivudine (Norvir, NORVIR) | 1件: Lopinavir Lopinavir | 1件: Lopinavir
Lopinavir
💬
| - | - | 1件: 265 265 💬
|
| 93 | Mavenclad 10MG TBL NOB | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 94 | Metronidazole (Noritate, NORITATE) | 1件: Metronidazole Metronidazole | 2件: Metronidazole
Metronidazole
(Noritate, NORITATE),
Metronidazole hydrochloride
💬
| - | - | 7件: 46 46, 51, 63, 94, 96, 97, 291 💬
|
| 95 | Metronidazole capsule 50 MG (Noritate, NORITATE) | 1件: Metronidazole Metronidazole | 2件: Metronidazole
Metronidazole
(Noritate, NORITATE),
Metronidazole hydrochloride
💬
| - | - | 1件: 97 97 💬
|
| 96 | Metronidazole oral (Noritate, NORITATE) | 1件: Metronidazole Metronidazole | 2件: Metronidazole
Metronidazole
(Noritate, NORITATE),
Metronidazole hydrochloride
💬
| - | - | 1件: 96 96 💬
|
| 97 | Mitoxantrone (Novantron) | 1件: Mitoxantrone Mitoxantrone | 2件: Mitoxantrone hydrochloride
Mitoxantrone hydrochloride
(Novantron),
Mitoxantrone
💬
| - | - | 1件: 13 13 💬
|
| 98 | Mitoxantrone - immunomodulator (Novantron) | 1件: Mitoxantrone Mitoxantrone | 2件: Mitoxantrone hydrochloride
Mitoxantrone hydrochloride
(Novantron),
Mitoxantrone
💬
| - | - | 1件: 13 13 💬
|
| 99 | Mitoxantrone hydrochloride liposome injection (Novantron) | 1件: Mitoxantrone Mitoxantrone | 2件: Mitoxantrone hydrochloride
Mitoxantrone hydrochloride
(Novantron),
Mitoxantrone
💬
| - | - | 1件: 13 13 💬
|
| 100 | Monotherapy (lopinavir/ritonavir) + ABC/3TC (Norvir, NORVIR) | 1件: Lopinavir Lopinavir | 1件: Lopinavir
Lopinavir
💬
| - | - | 1件: 265 265 💬
|
| 101 | Nitric oxide (NOXIVENT 101, NOXIVENT 102) | 1件: Nitric Oxide Nitric Oxide | 1件: Nitric oxide
Nitric oxide
(NOXIVENT 101, NOXIVENT 102) 💬
| - | - | 8件: 51 51, 85, 86, 88, 97, 210, 294, 299 💬
|
| 102 | Nitric oxide 160 PPM (NOXIVENT 101, NOXIVENT 102) | 1件: Nitric Oxide Nitric Oxide | 1件: Nitric oxide
Nitric oxide
(NOXIVENT 101, NOXIVENT 102) 💬
| - | - | 1件: 299 299 💬
|
| 103 | Nitric oxide FOR inhalation (NOXIVENT 101, NOXIVENT 102) | 1件: Nitric Oxide Nitric Oxide | 1件: Nitric oxide
Nitric oxide
(NOXIVENT 101, NOXIVENT 102) 💬
| - | - | 2件: 86 86, 299 💬
|
| 104 | Nitric oxide generated BY THE geno nitrosyl delivery system (NOXIVENT 101, NOXIVENT 102) | 1件: Nitric Oxide Nitric Oxide | 1件: Nitric oxide
Nitric oxide
(NOXIVENT 101, NOXIVENT 102) 💬
| - | - | 1件: 86 86 💬
|
| 105 | Nitric oxide plus oxygen (NOXIVENT 101, NOXIVENT 102) | 2件: Nitric Oxide Nitric Oxide, Oxygen | 2件: Oxygen
Oxygen
,
Nitric oxide
(NOXIVENT 101, NOXIVENT 102) 💬
| - | - | 1件: 86 86 💬
|
| 106 | Nitric oxide supplement (NOXIVENT 101, NOXIVENT 102) | 1件: Nitric Oxide Nitric Oxide | 1件: Nitric oxide
Nitric oxide
(NOXIVENT 101, NOXIVENT 102) 💬
| - | - | 1件: 251 251 💬
|
| 107 | NO active treatment | - | - | - | - | 1件: 274 274 💬
|
| 108 | NO ANTI-inflammatory treatment | - | - | - | - | 1件: 271 271 💬
|
| 109 | NO doxycycline | 1件: Doxycycline Doxycycline | 5件: Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | 1件: 299 299 💬
|
| 110 | NO enzyme therapy | - | - | - | - | 1件: 298 298 💬
|
| 111 | NO intervention, will NOT receive ANY active study intervention | - | - | - | - | 2件: 90 90, 303 💬
|
| 112 | NO intervention- observational SUB-study | - | - | - | - | 1件: 226 226 💬
|
| 113 | NO interventional drug product utilized IN this follow-UP study | - | - | - | - | 1件: 20 20 💬
|
| 114 | NO investigational product | - | - | - | - | 1件: 19 19 💬
|
| 115 | NO IT treatment | - | - | - | - | 1件: 19 19 💬
|
| 116 | NO pancreatic enzyme replacement therapy | - | - | - | - | 1件: 299 299 💬
|
| 117 | NO plasma exchange | - | - | - | - | 2件: 43 43, 44 💬
|
| 118 | NO treatment | - | - | - | - | 2件: 53 53, 274 💬
|
| 119 | NO treatment ARM | - | - | - | - | 1件: 13 13 💬
|
| 120 | NO4bd03 | - | - | - | - | 1件: 6 6 💬
|
| 121 | Nociceptor flexor reflex | - | - | - | - | 1件: 149 149 💬
|
| 122 | Nocturnal oxygen , nocturnal BI-level positive pressure ventilation | - | - | - | - | 1件: 299 299 💬
|
| 123 | NOE-101 | - | - | - | - | 1件: 158 158 💬
|
| 124 | Nolpitantium besylate | - | - | - | - | 1件: 97 97 💬
|
| 125 | Nomacopan | 1件: Nomacopan Nomacopan (Nomacopan) | 1件: Nomacopan
Nomacopan
(Nomacopan) 💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 162 162 💬
|
| 126 | Nomegestrol | 1件: Nomegestrol Nomegestrol (Nomegestrol) | 1件: Nomegestrol
Nomegestrol
(Nomegestrol) 💬
| 1件: PGR PGR 💬
| 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 13 13 💬
|
| 127 | Nomegestrol acetate | 2件: Nomegestrol Nomegestrol (Nomegestrol), Nomegestrol acetate (Nomegestrol acetate) | 2件: Nomegestrol
Nomegestrol
(Nomegestrol),
Nomegestrol acetate
(Nomegestrol acetate) 💬
| 1件: PGR PGR 💬
| 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 13 13 💬
|
| 128 | Nomlabofusp | 1件: Nomlabofusp Nomlabofusp (Nomlabofusp) | - | - | - | 1件: 18 18 💬
|
| 129 | NON applicabile | - | - | - | - | 3件: 49 49, 51, 256 💬
|
| 130 | NON applicable | - | - | - | - | 2件: 10 10, 19 💬
|
| 131 | NON AS OF YET | - | - | - | - | 1件: 97 97 💬
|
| 132 | NON ATG conditioning regimen | - | - | - | - | 1件: 60 60 💬
|
| 133 | NON commercial | - | - | - | - | 1件: 75 75 💬
|
| 134 | NON disponibile | - | - | - | - | 2件: 13 13, 201 💬
|
| 135 | NON intervention-genetic testing | - | - | - | - | 1件: 6 6 💬
|
| 136 | NON intervention-monitoring device | - | - | - | - | 1件: 6 6 💬
|
| 137 | NON invasive prenatal diagnosis | - | - | - | - | 3件: 8 8, 113, 206 💬
|
| 138 | NON invasive ventilation | - | - | - | - | 1件: 299 299 💬
|
| 139 | NON propietry, therefore N/A | - | - | - | - | 1件: 51 51 💬
|
| 140 | NON-active stimulation | - | - | - | - | 1件: 46 46 💬
|
| 141 | NON-ANTI-TNF biologics | - | - | - | - | 2件: 46 46, 271 💬
|
| 142 | NON-biologic ANTI-rheumatic drugs | - | - | - | - | 1件: 46 46 💬
|
| 143 | NON-biologic dmards | - | - | - | - | 3件: 46 46, 86, 107 💬
|
| 144 | NON-biological dmards | - | - | - | - | 1件: 46 46 💬
|
| 145 | NON-enteric coated pancreatic enzyme preparation | - | - | - | - | 1件: 298 298 💬
|
| 146 | NON-exposed group | - | - | - | - | 1件: 97 97 💬
|
| 147 | NON-genotyping | - | - | - | - | 1件: 97 97 💬
|
| 148 | NON-hormonal period | - | - | - | - | 1件: 299 299 💬
|
| 149 | NON-mavacamten symptomatic ohcm therapy | 1件: Mavacamten Mavacamten | 1件: Mavacamten
Mavacamten
💬
| 1件: MYH6_7 MYH6_7 💬
| 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cardiac muscle contraction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Motor proteins, Thyroid hormone signaling pathway, Viral myocarditis, cGMP-PKG signaling pathway 💬 | 1件: 58 58 💬
|
| 150 | NON-motor symptoms | - | - | - | - | 1件: 6 6 💬
|
| 151 | NON-nucleoside reverse transcriptase inhibitors | - | - | - | - | 1件: 265 265 💬
|
| 152 | NON-pegylated interferon | - | - | - | - | 1件: 13 13 💬
|
| 153 | NON-steroidal ANTI-inflammatory drug | - | - | - | - | 1件: 46 46 💬
|
| 154 | NON-steroidal ANTI-inflammatory drugs | - | - | - | - | 1件: 46 46 💬
|
| 155 | NON-steroidal mineralocorticoid receptor antagonist and SOC | - | - | - | - | 1件: 66 66 💬
|
| 156 | NON-TNFI-biologic class | - | - | - | - | 1件: 46 46 💬
|
| 157 | Nonbiologic dmards OF investigator'S choice | - | - | - | - | 1件: 46 46 💬
|
| 158 | None AS OF YET | - | - | - | - | 1件: 46 46 💬
|
| 159 | None assigned | - | - | - | - | 2件: 231 231, 299 💬
|
| 160 | None AT this time | - | - | - | - | 2件: 96 96, 140 💬
|
| 161 | None given | - | - | - | - | 1件: 97 97 💬
|
| 162 | None YET | - | - | - | - | 3件: 51 51, 85, 222 💬
|
| 163 | Noninvasive actigraphy monitor | - | - | - | - | 1件: 86 86 💬
|
| 164 | Nonmyeloablative allogeneic hematopoietic stem cell transplantation | - | - | - | - | 6件: 28 28, 51, 60, 62, 65, 285 💬
|
| 165 | Norantipyrine | - | - | - | - | 1件: 2 2 💬
|
| 166 | Nordimet 7,5 MG solution injectable EN stylo PRérempli | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 46 46 💬
|
| 167 | Norditropin | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
(NORDITROPIN) 💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 195 195 💬
|
| 168 | Norditropin 24 IU | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
(NORDITROPIN) 💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 195 195 💬
|
| 169 | Norditropin flexpro 10 MG/1.5 ML, solution FOR injection IN PRE-filled PEN | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
(NORDITROPIN) 💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 195 195 💬
|
| 170 | Norditropin simplexx | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
(NORDITROPIN) 💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 3件: 97 97, 193, 195 💬
|
| 171 | Norditropin simplexx 15 MG/1.5 ML | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
(NORDITROPIN) 💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 3 3 💬
|
| 172 | Norditropin simplexx 5MG/1.5ML | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
(NORDITROPIN) 💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 107 107 💬
|
| 173 | Norditropine simplex | - | - | - | - | 1件: 238 238 💬
|
| 174 | Norditropin® simplexx® 5MG/1.5ML | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
(NORDITROPIN) 💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 97 97 💬
|
| 175 | Norepinephrine | 1件: Norepinephrine Norepinephrine (Norepinephrine bitartrate) | 3件: Noradrenaline
Noradrenaline
(Noradrenaline, Norepinephrine, Nor adrenalin),
Norepinephrine bitartrate
(Norepinephrine bitartrate, LEVOPHED(R) NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE, NOREPINEPHR BITART),
Norepinephrine hydrochoride
(Norepinephrine hydrochoride, (-)-Noradrenaline hydrochloride) 💬
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 22 22 💬
|
| 176 | Norepinephrine bitartrate | 1件: Norepinephrine Norepinephrine (Norepinephrine bitartrate) | 3件: Noradrenaline
Noradrenaline
(Noradrenaline, Norepinephrine, Nor adrenalin),
Norepinephrine bitartrate
(Norepinephrine bitartrate, LEVOPHED(R) NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE, NOREPINEPHR BITART),
Norepinephrine hydrochoride
(Norepinephrine hydrochoride, (-)-Noradrenaline hydrochloride) 💬
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 296 296 💬
|
| 177 | Norethindrone | 1件: Norethisterone Norethisterone (17α-ethynyl-17β-hydroxy-19-norandrost-4-en-3-one) | 2件: Norethindrone
Norethindrone
(Norethindrone, Norethisterone),
Norethindrone acetate
(Norethindrone acetate, Norethisterone acetate) 💬
| 1件: PGR PGR 💬
| 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 4件: 13 13, 46, 49, 299 💬
|
| 178 | Normal (control) diet | - | - | - | - | 1件: 240 240 💬
|
| 179 | Normal diet | - | - | - | - | 2件: 96 96, 97 💬
|
| 180 | Normal dietetic scheme | - | - | - | - | 1件: 97 97 💬
|
| 181 | Normal human immunoglobulin G | - | - | - | - | 1件: 65 65 💬
|
| 182 | Normal oral intake OF THE traditional formula | - | - | - | - | 1件: 296 296 💬
|
| 183 | Normal saline | - | - | - | - | 20件: 6 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 97, 210, 211, 222, 226, 276, 280, 296, 299 💬
|
| 184 | Normal saline 0.9% infusion solution | - | - | - | - | 1件: 22 22 💬
|
| 185 | Normal saline enema | - | - | - | - | 1件: 97 97 💬
|
| 186 | Normal saline FOR injection | - | - | - | - | 2件: 13 13, 84 💬
|
| 187 | Normal saline instillation | - | - | - | - | 1件: 226 226 💬
|
| 188 | Normal saline IV administration | - | - | - | - | 1件: 65 65 💬
|
| 189 | Normal saline IV, salt tablets | - | - | - | - | 1件: 299 299 💬
|
| 190 | Normal saline solution | 1件: Sodium chloride Sodium chloride | 1件: Sodium chloride
Sodium chloride
💬
| - | - | 1件: 299 299 💬
|
| 191 | Normix*AD 12CPR RIV 200MG | - | - | - | - | 1件: 96 96 💬
|
| 192 | Norovirus -specific T-cell (NST) therapy | - | - | - | - | 1件: 65 65 💬
|
| 193 | Norphenazone | 1件: Edaravone Edaravone (Norphenazone) | 1件: Edaravone
Edaravone
💬
| - | - | 1件: 2 2 💬
|
| 194 | Northera | 1件: Droxidopa Droxidopa | 1件: Droxidopa
Droxidopa
(Northera, NORTHERA) 💬
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 195 | Nortriptyline | 1件: Nortriptyline Nortriptyline (Nortriptyline) | 2件: Nortriptyline hydrochloride
Nortriptyline hydrochloride
(Nortriptyline hydrochloride, NORTRIPTYLINE HCL, NORTRIPTYLINE HYDROCHLORIDE),
Nortriptyline
(Nortriptyline, Nortrilen) 💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 226 💬
|
| 196 | Nortriptyline hydrochloride | 1件: Nortriptyline Nortriptyline (Nortriptyline) | 2件: Nortriptyline hydrochloride
Nortriptyline hydrochloride
(Nortriptyline hydrochloride, NORTRIPTYLINE HCL, NORTRIPTYLINE HYDROCHLORIDE),
Nortriptyline
(Nortriptyline, Nortrilen) 💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 6 6 💬
|
| 197 | Norucholic acid | 1件: norUrsodeoxycholic acid norUrsodeoxycholic acid (Norucholic acid) | - | - | - | 1件: 94 94 💬
|
| 198 | Norucholic acid (NCA) 500 MG | 1件: norUrsodeoxycholic acid norUrsodeoxycholic acid (Norucholic acid) | - | - | - | 1件: 93 93 💬
|
| 199 | Norudca | - | - | - | - | 1件: 94 94 💬
|
| 200 | Norursodeoxycholic acid | 1件: norUrsodeoxycholic acid norUrsodeoxycholic acid (Norucholic acid) | - | - | - | 1件: 94 94 💬
|
| 201 | Norursodeoxycholic acid, NCA | 1件: norUrsodeoxycholic acid norUrsodeoxycholic acid (Norucholic acid) | - | - | - | 1件: 94 94 💬
|
| 202 | Norvir | 1件: Ritonavir Ritonavir | 1件: Ritonavir
Ritonavir
(Norvir, NORVIR) 💬
| - | - | 1件: 265 265 💬
|
| 203 | Norvir 100 MG FILM-coated tablets | - | - | - | - | 1件: 299 299 💬
|
| 204 | NOT applicable | - | - | - | - | 1件: 13 13 💬
|
| 205 | NOT YET assigned | - | - | - | - | 2件: 36 36, 97 💬
|
| 206 | Novantrone*INF 2MG/ML 5ML | 1件: Mitoxantrone Mitoxantrone | 2件: Mitoxantrone hydrochloride
Mitoxantrone hydrochloride
(Novantron),
Mitoxantrone
💬
| - | - | 1件: 13 13 💬
|
| 207 | Novartis pharmaceuticals corporation | - | - | - | - | 1件: 13 13 💬
|
| 208 | Novatrex | - | - | - | - | 1件: 13 13 💬
|
| 209 | Novo rapid | - | - | - | - | 1件: 299 299 💬
|
| 210 | Novolin-R insulin | - | - | - | - | 1件: 127 127 💬
|
| 211 | Novonorm 0.5 MG | - | - | - | - | 1件: 299 299 💬
|
| 212 | Novonorm 1 MG | - | - | - | - | 1件: 299 299 💬
|
| 213 | Novonorm 2 MG | - | - | - | - | 1件: 299 299 💬
|
| 214 | Novorapid / humalog short acting insulin | - | - | - | - | 1件: 299 299 💬
|
| 215 | Novorapid aspartate | - | - | - | - | 1件: 299 299 💬
|
| 216 | NOW foods L-ornithine capsules | - | - | - | - | 1件: 96 96 💬
|
| 217 | NOX-E36 | - | - | - | - | 1件: 49 49 💬
|
| 218 | Noxafil | 1件: Posaconazole Posaconazole | 1件: Posaconazole
Posaconazole
(Noxafil, NOXAFIL) 💬
| - | - | 1件: 299 299 💬
|
| 219 | Noxafil - 40 MG/ML sospensione orale USO orale flacone (vetro) 105 ML 1 flacone | - | - | - | - | 1件: 299 299 💬
|
| 220 | Noxafil - oral suspension 40 MG/ML | 1件: Posaconazole Posaconazole | 1件: Posaconazole
Posaconazole
(Noxafil, NOXAFIL) 💬
| - | - | 1件: 299 299 💬
|
| 221 | Noxafil 100 MG | 1件: Posaconazole Posaconazole | 1件: Posaconazole
Posaconazole
(Noxafil, NOXAFIL) 💬
| - | - | 1件: 299 299 💬
|
| 222 | Noxafil 100 MG tablets gastro-resistant | 1件: Posaconazole Posaconazole | 1件: Posaconazole
Posaconazole
(Noxafil, NOXAFIL) 💬
| - | - | 1件: 299 299 💬
|
| 223 | Noxafil 40 MG/ML oral solution | 1件: Posaconazole Posaconazole | 1件: Posaconazole
Posaconazole
(Noxafil, NOXAFIL) 💬
| - | - | 1件: 65 65 💬
|
| 224 | Noxafil gastro resistant tablets | - | - | - | - | 1件: 60 60 💬
|
| 225 | Occlusive NON adherent dressing | - | - | - | - | 1件: 36 36 💬
|
| 226 | Ortho-cyclen, ethinyl estradiol/norgestimate, 0.035 MG/0.250 MG | - | - | - | - | 1件: 299 299 💬
|
| 227 | Ortho-novum 777 | - | - | - | - | 1件: 49 49 💬
|
| 228 | Ortho-novum® 1/35 | - | - | - | - | 1件: 46 46 💬
|
| 229 | Other NON steroidal ANTI-inflammatory drugs (nsaids) except etodolac | - | - | - | - | 1件: 46 46 💬
|
| 230 | Other NON-selective nsaids | - | - | - | - | 1件: 271 271 💬
|
| 231 | Other NON-sponsor pancreatic enzyme replacement therapy | - | - | - | - | 1件: 299 299 💬
|
| 232 | Paracetamolo nova argentia - 500 MG compresse 20 compresse | - | - | - | - | 1件: 300 300 💬
|
| 233 | Patients' existing NON-steroidal ANTI-inflammatory drug (nsaid) AT approved doses | - | - | - | - | 1件: 46 46 💬
|
| 234 | PK-merz® 200MG/500ML INJ(amantadine) , normal saline 500ML INJ | - | - | - | - | 1件: 6 6 💬
|
| 235 | Posaconazole (Noxafil, NOXAFIL) | 1件: Posaconazole Posaconazole | 1件: Posaconazole
Posaconazole
(Noxafil, NOXAFIL) 💬
| - | - | 3件: 60 60, 65, 299 💬
|
| 236 | Posaconazole 40 MG/ML (Noxafil, NOXAFIL) | 1件: Posaconazole Posaconazole | 1件: Posaconazole
Posaconazole
(Noxafil, NOXAFIL) 💬
| - | - | 1件: 299 299 💬
|
| 237 | Posaconazole delayed release oral tablet (Noxafil, NOXAFIL) | 1件: Posaconazole Posaconazole | 1件: Posaconazole
Posaconazole
(Noxafil, NOXAFIL) 💬
| - | - | 1件: 96 96 💬
|
| 238 | Prednison 5, 20 Léciva POR. tablet NOB | - | - | - | - | 1件: 50 50 💬
|
| 239 | Quetiapine (Norsic) | 1件: Quetiapine Quetiapine | 2件: Quetiapine fumarate
Quetiapine fumarate
,
Quetiapine
(Norsic) 💬
| 2件: DRD2 DRD2, HTR2 💬
| 13件: Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 240 | Rebif NEW formulation NON titrated | - | - | - | - | 1件: 13 13 💬
|
| 241 | Regular novolin R | - | - | - | - | 1件: 6 6 💬
|
| 242 | Rhasa [recombinant human arylsulfatase A], formerly HGT-1110, NOW also known AS TAK-611 | - | - | - | - | 1件: 19 19 💬
|
| 243 | Rifampin (RIFADIN IV NOVAPLUS) | 1件: Rifampin Rifampin | 2件: Rifampin
Rifampin
(RIFADIN IV NOVAPLUS),
Rifampicin sodium
💬
| - | - | 4件: 13 13, 84, 86, 299 💬
|
| 244 | Rifampin 300MG BID + istradefylline 40MG DAY 8 only (Nourianz, Nouriast, NOURIANZ) | 2件: Istradefylline Istradefylline, Rifampin | 3件: Rifampin
Rifampin
(RIFADIN IV NOVAPLUS),
Istradefylline
(Nourianz, Nouriast, NOURIANZ),
Rifampicin sodium
💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 245 | Ritonavir (Norvir, NORVIR) | 1件: Ritonavir Ritonavir | 1件: Ritonavir
Ritonavir
(Norvir, NORVIR) 💬
| - | - | 3件: 2 2, 86, 265 💬
|
| 246 | Rokan (R) novo 120 MG | - | - | - | - | 1件: 18 18 💬
|
| 247 | Ropivacaine plus normal saline | 1件: Ropivacaine Ropivacaine | 2件: Ropivacaine hydrochloride
Ropivacaine hydrochloride
,
Ropivacaine
💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 70 70 💬
|
| 248 | Rozanolixizumab (rozanolixizumab-noli) | 1件: Rozanolixizumab Rozanolixizumab | 1件: Rozanolixizumab
Rozanolixizumab
(rozanolixizumab-noli) 💬
| - | - | 3件: 11 11, 14, 63 💬
|
| 249 | Saquinavir and ritonavir (Norvir, NORVIR) | 1件: Saquinavir Saquinavir | 2件: Saquinavir
Saquinavir
,
Saquinavir mesylate
💬
| - | - | 1件: 86 86 💬
|
| 250 | Somatotropin (NORDITROPIN) | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
(NORDITROPIN) 💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 2件: 3 3, 65 💬
|
| 251 | Sterile normal saline FOR intravenous USE | - | - | - | - | 2件: 85 85, 229 💬
|
| 252 | Systemic NON-biological treatments | - | - | - | - | 2件: 46 46, 271 💬
|
| 253 | Tamoxifen (Nolvadex) | 1件: Tamoxifen Tamoxifen | 2件: Tamoxifen citrate
Tamoxifen citrate
(Nolvadex),
Tamoxifen
💬
| 2件: ESR1 ESR1, ESR2 💬
| 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 4件: 2 2, 86, 113, 227 💬
|
| 254 | Tamoxifen 20MG hexal® filmtabletten (Nolvadex) | 1件: Tamoxifen Tamoxifen | 2件: Tamoxifen citrate
Tamoxifen citrate
(Nolvadex),
Tamoxifen
💬
| 2件: ESR1 ESR1, ESR2 💬
| 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 113 113 💬
|
| 255 | Tamoxifen 40 MG daily FOR ONE year (Nolvadex) | 1件: Tamoxifen Tamoxifen | 2件: Tamoxifen citrate
Tamoxifen citrate
(Nolvadex),
Tamoxifen
💬
| 2件: ESR1 ESR1, ESR2 💬
| 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 2 2 💬
|
| 256 | Tamoxifen citrate (Nolvadex) | 1件: Tamoxifen Tamoxifen | 2件: Tamoxifen citrate
Tamoxifen citrate
(Nolvadex),
Tamoxifen
💬
| 2件: ESR1 ESR1, ESR2 💬
| 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 113 113 💬
|
| 257 | There IS NO recommended INN | - | - | - | - | 1件: 65 65 💬
|
| 258 | TNF-A antagonists, NON-tnfs, dmard NON-biologics | - | - | - | - | 3件: 46 46, 97, 271 💬
|
| 259 | Topotecan (Nogitecan hydrochloride) | 1件: Topotecan Topotecan | 2件: Topotecan hydrochloride
Topotecan hydrochloride
(Nogitecan hydrochloride),
Topotecan
💬
| - | - | 1件: 25 25 💬
|
| 260 | Triamcinolone acetonide and normal saline solution | 1件: Triamcinolone Triamcinolone | 4件: Triamcinolone
Triamcinolone
,
Triamcinolone acetonide
,
Triamcinolone diacetate
,
Triamcinolone hexacetonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 70 70 💬
|
| 261 | VTX002 IS NOT biologic | - | - | - | - | 1件: 97 97 💬
|
| 262 | Zofran - NO intubation | - | - | - | - | 1件: 98 98 💬
|
| 263 | Zuoqing powder WAS dissolved IN 100ML normal saline, retained enema, once A night | - | - | - | - | 1件: 97 97 💬
|